Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for IM Cannabis (IMCC) over the last 6 years, with Q2 2025 value amounting to -$1.8 million.

  • IM Cannabis' Change in Accured Expenses fell 23152.52% to -$1.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.3 million, marking a year-over-year decrease of 37710.76%. This contributed to the annual value of -$5.2 million for FY2024, which is 83909.02% down from last year.
  • As of Q2 2025, IM Cannabis' Change in Accured Expenses stood at -$1.8 million, which was down 23152.52% from $3.9 million recorded in Q1 2025.
  • In the past 5 years, IM Cannabis' Change in Accured Expenses ranged from a high of $11.4 million in Q4 2022 and a low of -$6.8 million during Q4 2024
  • Its 5-year average for Change in Accured Expenses is $409058.8, with a median of -$325443.5 in 2021.
  • Over the last 5 years, IM Cannabis' Change in Accured Expenses had its largest YoY gain of 32576.07% in 2021, and its largest YoY loss of 6675037.14% in 2021.
  • Over the past 5 years, IM Cannabis' Change in Accured Expenses (Quarter) stood at $6.2 million in 2021, then skyrocketed by 83.82% to $11.4 million in 2022, then plummeted by 106.55% to -$745553.5 in 2023, then tumbled by 818.58% to -$6.8 million in 2024, then surged by 73.98% to -$1.8 million in 2025.
  • Its Change in Accured Expenses stands at -$1.8 million for Q2 2025, versus $3.9 million for Q1 2025 and -$6.8 million for Q4 2024.